ArticleRegulatory toxicology and pharmacology : RTP2025
Substantiating chemical groups for read-across using molecular response profiles.
Article in Regulatory toxicology and pharmacology : RTP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Applicability of NAMs to support a read-across based hazard assessment workflow for systemic toxicity: a conazole case study.Archives of toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
By grouping structurally similar chemicals, toxicity endpoints from data-rich substances can be read across to data-poor substances, supporting environmental and human health risk assessment without animal testing. However, structural similarity alone is insufficient, and additional supporting data can strengthen a grouping justification. This study aimed to demonstrate how multi-omics bioactivity data can increase confidence in a grouping hypothesis, where the bioactivity profiles can reflect a chemical's mode(s) of action. We investigated three structurally similar phthalates and three uncouplers of oxidative phosphorylation, applying structure-based grouping approaches and short-term exposures of the ecotoxicological test species Daphnia magna to generate multi-omics data. Bioactivity similarities between the 'omics responses to chemical exposure were assessed using t-statistics comparing treated samples to controls and visualised using hierarchical cluster analysis. Conventional structure-based grouping did not assign the phthalates and uncouplers into two anticipated categories, with the structurally more diverse uncouplers often assigned into multiple groups. Following bioactivity thresholding, which removed one uncoupler as it induced minimal molecular responses, bioactivity profile-based grouping of the remaining five substances correctly separated them into two chemical classes with high replicability confidence. However, a plausible toxicological interpretation of the reduced set of functionally annotated molecular features driving the grouping was attempted, although of limited success. This study demonstrates how multi-omics bioactivity profiles can increase confidence in chemical grouping and investigates a potential strategy for plausibly interpreting 'omics data.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.